Hepatitis B virus reactivation is a risk factor for development of post-transplant lymphoproliferative disease after liver transplantation

Clinical Transplantation

Volumn 23, Issue 5, 2009, Pages 756-760

  Zhang, Aibin ^a   Zhang, Min ^a   Shen, Yan ^a   Wang, Weilin ^a   Zheng, Shusen ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Hepatitis B virus; Liver transplantation; Lymphoma; Lymphotropic virus; Post transplant lymphoproliferative disorder

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT REJECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER DISEASE; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VIRUS REACTIVATION;

ADULT; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS; VIRUS ACTIVATION;

EID: 70350164877     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01049.x     Document Type: Article

References (22)

1. Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004, 4:222.
2. Muti G, Cantoni S, Oreste P. Post-transplants lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment. Haematologica 2002, 87:67.
3. Duvoux C, Pageaux GP, Vanlemmens C. Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients. Transplantation 2002, 74:1103.
4. Jain A, Nalesnik M, Reyes J. ost-transplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg 2002, 36:429.
5. Cockfield SM. Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 2001, 3:70.
6. Aucejo F, Rofaiel G, Miller C. Who is at risk for posttransplant lymphoproliferative disorders (PTLD) after liver transplantation?. J Hepatol 2006, 44:19-23.
7. McLaughlin K, Wajstaub S, Marotta P. Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C. Liver Transpl 2000, 6:570.
8. Ulcickas Yood M, Quesenberry CP, Guo D. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection. Hepatology 2007, 46:107.
9. Wang F, Xu RH, Han B. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer 2007, 109:1360.
10. Li YH, He YF, Jiang WQ. Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma. Cancer 2006, 106:1320.
11. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982, 49:2112.
12. Guthery SL, Heubi JE, Bucuvalas JC. Determination of risk factors for EBV-associated post-transplant lymphoproliferative disorders in pediatric liver transplant recipients using objective case ascertainment. Transplantation 2003, 75:987.
13. Norin S, Kimby E, Ericzon BG. Posttransplant lymphoma - a single-center experience of 500 liver transplantations. Med Oncol 2004, 21:273.
14. Chardot C, Nicoluzzi JE, Janssen M. Use of mycophenolate mofetil as rescue therapy after pediatric liver transplantation. Transplantation 2001, 71:224.
15. Marino IR, Doria C, Scott VL. Efficacy and safety of basiliximab with a tacrolimus-based regimen in liver transplant recipients. Transplantation 2004, 78:886.
16. Smets F, Latinne D, Bazin H. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. Transplantation 2002, 73:1603.
17. Scheenstra R, Verschuuren EA, De Haan A. The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients. Transpl Infect Dis 2004, 6:15.
18. Kim JH, Bang YJ, Park BJ. Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study. Jpn J Cancer Res 2002, 93:471.
19. Heimann R, Lespagnard L, Desmet V. Pathogenic role of hepatitis B virus (HBV). Am J Pathol 1995, 147:223.
20. Rui L, Goodnow CC. Lymphoma and the control of B cell growth and differentiation. Curr Mol Med 2006, 6:291.
21. Dewantoro O, Gani RA, Akbar N. Hepatocarcinogenesis in viral hepatitis B infection: the role of HBx and p53. Acta Med Indones 2006, 38:154.
22. Leung N. HBV and liver cancer. Med J Malaysia 2005, 6:63.